Views & Analysis | Perspectives on pharma industry issues

Digital

Two female silhouettes in a city office overlook the urban landscape below

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Patients

Maintenance: The underexamined half of the GLP-1 story

GLP-1 treatments have historically had an exit problem, as appetite suppression stops when the medication stops.

Oncology

pharmaphorum podcast Episode 276, Irina Babina, Concr

Getting predictive technologies to patients, with Concr

Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Articles

A day in the life of... a Director of Scientific Services at...

Elif Fincanci-Smith, Director of Scientific Services at Darwin Healthcare Communications shares the rewards and challenges of her role and explains what a typical day looks like for her. Continuing our new series where we speak with individuals from various roles and functions across the pharmaceutical industry on what a...

Articles

A day in the life of... an Associate Partner at MMRG (Medica...

Helen Taylor, Associate Partner at MMRG (Medical Marketing Research Group) shares what it’s like to work in her role. Continuing our new series where we speak with individuals from various roles and functions across the pharmaceutical industry on what a...

Articles

Rare disease awareness: Alkaptonuria

Are enough questions being asked of patients who don’t present with typical symptoms of common diseases? Oliver Timmis of the AKU society doesn’t think so and here he explains why doing so could increase rare disease recognition and reduce patient isolation. There are approximately 7000 rare diseases and many patients suffering from them unfortunately face years of misdiagnosis and...

Sales & Marketing

Accelerating growth through strategic investment in healthca...

CEVA FORPATIENTS at Rockingham, UK will offer the healthcare supply chain a new, sustainably designed multi-user site.

Sales & Marketing

The patient communication crisis pharma can no longer ignore

Industry's significant investments in patient engagement are only effective if patients trust the communication enough to answer in the first place.

Digital

How female leadership can benefit industry

Day One Strategy’s founding partners Abigail Stuart and Hannah Mann share the benefits female leadership can bring to industry.

Digital

Pharma brands face golden opportunity to extend supply chain...

People are ready for technology that verifies authenticity and provides helpful information directly from the medicinal product itself.

Market Access

$100 notes in pill bottle on aquamarine background with spilled pills

How new PBM transparency rules will alter drug pricing

The complex drug pricing ecosystem means all stakeholders are scrambling to understand how the new regulations and PBMs’ adjustments will impact them.

Market Access